Forsta Ap Fonden Quest Diagnostics Inc Transaction History

Forsta Ap Fonden

$12.8 Billion
Q3 2024

A detailed history of Forsta Ap Fonden transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 28,600 shares of DGX stock, worth $3.92 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,600

Previous 25,300 13.04%

Holding current value

$3.92 Million

Previous $3.46 Million 13.2%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$137.09 - $137.09 $452,397 - $452,397	3,300 Added 13.04%	28,600 $3.92 Million
Q2 2024 Aug 08, 2024	SELL	$125.91 - $144.34 $881,370 - $1.01 Million	-7,000 Reduced 21.67%	25,300 $3.46 Million
Q1 2024 May 07, 2024	SELL	$123.78 - $142.11 $668,412 - $767,394	-5,400 Reduced 14.32%	32,300 $4.3 Million
Q4 2023 Feb 06, 2024	SELL	$120.62 - $141.12 $2.63 Million - $3.08 Million	-21,800 Reduced 36.64%	37,700 $5.2 Million
Q3 2023 Oct 25, 2023	BUY	$121.86 - $144.92 $304,650 - $362,299	2,500 Added 4.39%	59,500 $7.25 Million
Q2 2023 Aug 03, 2023	SELL	$130.56 - $146.84 $1.28 Million - $1.44 Million	-9,800 Reduced 14.67%	57,000 $8.01 Million
Q1 2023 Apr 21, 2023	BUY	$131.53 - $155.76 $473,508 - $560,736	3,600 Added 5.7%	66,800 $9.45 Million
Q4 2022 Feb 02, 2023	BUY	$123.31 - $157.26 $283,613 - $361,698	2,300 Added 3.78%	63,200 $9.89 Million
Q3 2022 Oct 17, 2022	SELL	$121.77 - $141.1 $511,434 - $592,620	-4,200 Reduced 6.45%	60,900 $7.47 Million
Q2 2022 Aug 11, 2022	BUY	$127.07 - $145.39 $6.21 Million - $7.11 Million	48,900 Added 301.85%	65,100 $8.66 Million
Q1 2022 May 09, 2022	SELL	$129.09 - $164.35 $4.16 Million - $5.29 Million	-32,200 Reduced 66.53%	16,200 $2.22 Million
Q4 2021 Feb 11, 2022	SELL	$140.36 - $173.01 $1.99 Million - $2.46 Million	-14,200 Reduced 22.68%	48,400 $8.37 Million
Q3 2021 Nov 10, 2021	BUY	$132.95 - $158.0 $5.12 Million - $6.08 Million	38,500 Added 159.75%	62,600 $9.1 Million
Q2 2021 Aug 12, 2021	SELL	$126.66 - $141.48 $1.39 Million - $1.56 Million	-11,000 Reduced 31.34%	24,100 $3.18 Million
Q1 2021 May 11, 2021	SELL	$114.63 - $133.34 $3.08 Million - $3.59 Million	-26,900 Reduced 43.39%	35,100 $4.51 Million
Q4 2020 Feb 09, 2021	BUY	$112.7 - $128.05 $2.52 Million - $2.87 Million	22,400 Added 56.57%	62,000 $7.39 Million
Q3 2020 Oct 22, 2020	SELL	$107.05 - $130.01 $2.32 Million - $2.82 Million	-21,688 Reduced 35.39%	39,600 $4.53 Million
Q2 2020 Aug 11, 2020	SELL	$73.34 - $122.61 $168,682 - $282,003	-2,300 Reduced 3.62%	61,288 $6.98 Million
Q1 2020 May 04, 2020	BUY	$75.14 - $115.68 $1.91 Million - $2.94 Million	25,400 Added 66.51%	63,588 $5.11 Million
Q4 2019 Feb 12, 2020	BUY	$100.29 - $107.99 $501,450 - $539,950	5,000 Added 15.07%	38,188 $4.08 Million
Q3 2019 Nov 13, 2019	BUY	$97.85 - $107.42 $78,280 - $85,936	800 Added 2.47%	33,188 $3.55 Million
Q2 2019 Aug 07, 2019	SELL	$85.18 - $101.94 $417,382 - $499,506	-4,900 Reduced 13.14%	32,388 $3.3 Million
Q1 2019 May 08, 2019	SELL	$80.68 - $89.92 $112,952 - $125,888	-1,400 Reduced 3.62%	37,288 $3.35 Million
Q4 2018 Feb 11, 2019	SELL	$79.75 - $108.38 $279,125 - $379,330	-3,500 Reduced 8.3%	38,688 $3.22 Million
Q3 2018 Nov 07, 2018	SELL	$105.42 - $114.99 $221,382 - $241,479	-2,100 Reduced 4.74%	42,188 $4.55 Million
Q2 2018 Aug 15, 2018	SELL	$97.35 - $113.14 $184,965 - $214,966	-1,900 Reduced 4.11%	44,288 $4.87 Million
Q1 2018 May 09, 2018	SELL	$96.42 - $107.88 $704,058 - $787,739	-7,302 Reduced 13.65%	46,188 $4.63 Million
Q4 2017 Feb 08, 2018	SELL	$90.86 - $100.24 $899,514 - $992,376	-9,900 Reduced 15.62%	53,490 $5.27 Million
Q3 2017 Oct 31, 2017	BUY	$91.96 - $108.35 $5.83 Million - $6.87 Million	63,390	63,390 $5.94 Million

Others Institutions Holding DGX

# of Institutions

933

Shares Held

93.8M

Call Options Held

501K

Put Options Held

238K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account